Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2027–2029 · award
A shared Neoantigen Vaccine trial for BAP1-Inactivated Uveal Melanoma
Olivier Lantz · Institut Curie
2026–2029 · award
Development of a Covalent CARM1 Inhibitor for Immunotherapy of Melanoma
Kai Wucherpfennig · Dana-Farber Cancer Institute
2026–2031 · award
Targeting the melanoma metabolic microenvironment to boost T-cell therapy
Taha Merghoub · Weill Cornell Medicine
2026–2029 · award
Characterizing aneuploidy as a driver and vulnerability in melanoma
Jason Sheltzer · Stanford University
2026–2029 · award
Pathology assessment of response for immunotherapy-treated melanoma
Julie Deutsch · Johns Hopkins University
2026–2029 · award
Defining Drivers of Response and Resistance in Neoadjuvant Immunotherapy
Moshe Sade-Feldman · Massachusetts General Hospital
2026–2029 · award
Investigating IL-18BP blockade as a therapeutic strategy in melanoma
David Schoenfeld · Yale University
2026–2029 · award
Investigating the origins of acral melanoma
Richard White · University of Oxford
2026–2029 · award
Harnessing the lymph node as a discovery platform to target melanoma
Jessalyn Ubellacker · Harvard University
2026–2029 · award
Accelerating In Vivo TCR Therapy for Uveal Melanoma Targeting SLC45A2
Cassian Yee · The University of Texas MD Anderson Cancer Center
2026–2029 · award
Oncochromosomes and TERT as Foundational Drivers in Acral Melanoma
Boris Bastian · Regent University
2026–2029 · award
Targeting metabolism in therapy resistant and metastatic uveal melanoma
Andrew Aplin · Thomas Jefferson University
2026–2029 · award
Melanoma phenotypic heterogeneity driving resistance to immune therapies
Marcus Bosenberg · Yale University
2026–2029 · award
AI Prediction and Analysis of Chromosomal Instability in Melanoma Relapse
Benjamin Izar · Columbia University Irving Medical Center
2026–2028 · award
Blocking Extracellular HSP70 With Decoy Antibodies to Treat Melanoma
Natalia Freund · Tel Aviv University
2026–2028 · award
Spatial and AI-Powered Insights into Melanocytic Malignant Transformation
Paul Harms · Regent University
2026–2029 · award
Defining shared non-canonical tumor antigens for anti-melanoma vaccines
Patrick Ott · Dana-Farber Cancer Institute
2026–2029 · award
KLEAR-OCT for non-invasive detection of melanoma
Kavita Sarin · The Board Of Trustees Of The Leland Stanford Junior University
2026–2029 · award
Mapping and characterizing cellular niches in melanoma metastasis
Panagiotis Karras · Université Libre de Bruxelles
2026–2029 · award
Anti-evolutionary rotational MAPKi therapy to forestall resistance
Zhentao Yang · The Regents Of The University Of California, Los Angeles
2026–2028 · award
Enhancing CD8+ T cell responses to melanoma brain metastases
Arlene Sharpe · Harvard University
2026–2028 · award
Chromosome Y Loss in Melanoma
Todd Ridky · The Trustees Of The University Of Pennsylvania
2026–2028 · award
Deconstructing an IL33-Dependent Lymphatic Niche in Melanoma-Draining Lymph
Amanda Lund · New York University
2026–2029 · award
Castalagin prebiotic as a novel therapeutic modality for melanoma
Arielle Elkrief · Université de Montréal
2026–2029 · award
Tumor-Selective RAF Inhibitors for RAS- and BRAF Dimer–Driven Melanomas
Poulikos Poulikakos · Icahn School of Medicine at Mount Sinai
2026–2028 · award
Mechanism-Guided Biomarkers & Therapies in NRAS-mutant Melanoma
Hee Won Yang · Columbia University Irving Medical Center
2026–2029 · award
DP1 receptor signaling in aging-associated immune dysfunction in melanoma
Jian Zheng · University Of Louisville Research Foundation, Inc.
2026–2029 · award
Harnessing anti-tumor CD4+ TIL to improve melanoma immunotherapy response
Kellie Smith · Johns Hopkins University
2026–2029 · award
Dissecting circadian immunodynamics in melanoma
Daniel Kirschenbaum · German Cancer Research Center
2026–2029 · award
Engineer chemically induced stem-like T cells against melanoma
Chen Yao · The University Of Texas Southwestern Medical Center (ut Southwestern)
2026–2029 · award
Mechanisms of Acral Melanoma Progression and Metastasis
Dekker Deacon · University of Utah
2025–2030 · award
Rare Melanoma Consortium: Johns Hopkins University
Vito Rebecca · Johns Hopkins University Applied Physics Laboratory
2025–2027 · award
Acral Melanoma PDXs: Genomic Subtypes, Co-Mutations, and Metastatic Drivers
Roger Lo · The Regents Of The University Of California, Los Angeles
2025–2028 · award
Innovative Metalloimmunotherapy for Advanced Melanoma and Metastasis
Kevin Sun · Icahn School of Medicine at Mount Sinai
2025–2028 · award
New specific therapeutic approaches to target NF1-null Melanoma
Sandra Misale · Johns Hopkins University
2025–2027 · award
Next-Generation Models of AM to Map Therapeutic Vulnerabilities
Jessie Villanueva · The Wistar Institute
2025–2030 · award
Rare Melanoma Consortium: UT Southwestern
J. William Harbour · The University Of Texas Southwestern Medical Center (ut Southwestern)
2025–2028 · award
Targeting VISTA on neutrophils to manage immunotherapy adverse events
Daniel Hirschhorn · Weill Cornell Medicine
2025–2027 · award
Enabling precision drug delivery by targeting cancer metabolism
Xiaoyang Wu · University of Chicago
2025–2027 · award
Upregulating phospho-ERK as a new therapeutic approach
Drew Adams · Case Western Reserve University